EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

The Burden and Trends of Degenerative Mitral Valve Disease at the Global, Regional, and National Levels From 1990 to 2021, With Projections to 2035

Qiang Li iD, Yifan Yang iD, Zhi-Nan Lu, Xunan Guo iD, Xinmin Liu, Zhengming Jiang, Wenhui Wu, Chengqian Yin, Jianxin Li iD, Xiangfeng Lu iD, Guangyuan Song iD

Global Heart · 2025

DOI: 10.5334/gh.1489 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Global Heart, 2025. Verfasst von Qiang Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Center of Valvular Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Mitral Valve, Cost of Illness, Heart Valve Diseases. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Degenerative mitral valve disease (DMVD) is a significant contributor to the global burden of disease. This study aimed to estimate the prevalence, mortality, and disability-adjusted life years (DALYs) rates of DMVD at global, regional, and national levels from 1990 to 2021 and to project its future burden.

Methods

This study extracted three pivotal indicators, including the prevalence, mortality, and DALYs related to DMVD, from the Global Burden of Disease 2021. The average annual percentage change and rate change were utilized to evaluate the changes in the disease burden. Decomposition analyses were conducted to evaluate these changes. In addition, a Bayesian age-period-cohort analysis was performed to forecast the future burden of DMVD.

Results

In 2021, the global age-standardized prevalence rates (ASPRs), age-standardized mortality rates (ASMRs), and age-standardized disability-adjusted life year rates (ASDRs) for DMVD were 182.13 per 100,000 persons [95% uncertainty interval (UI): 169.952, 196.070], 0.456 per 100,000 persons (95% UI: 0.394, 0.514), and 11.362 per 100,000 persons (95% UI: 9.867, 13.611), respectively. Regions with a high sociodemographic index exhibited the most substantial disease burden. Women exhibited lower ASPR than men, but higher ASMR. Decomposition analyses reveal that improvements in DMVD burden were primarily attributable to epidemiological changes; however, it was negatively affected by population growth and aging. Predictive analysis suggests that global projections for DMVD in 2035 estimate approximately 21.41 million (95% UI: 15,718,776, 27,102,848) cases of prevalence, 47,878 (95% UI: 28,449, 67,307) cases of mortality, and 1.20 million (95% UI: 793,487, 1,615,972) cases of DALYs.

Conclusions

The global burden of DMVD, indicated in its age-standardized prevalence, mortality, and DALYs rates, exhibits significant declines. However, significant regional and national variations exist. Findings of our study emphasize the importance of devising targeted public health strategies tailored to different regions, countries, and populations, with the aim of further mitigating DMVD’s global impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral ValveCost of IllnessHeart Valve DiseasesHumansMaleFemalePrevalenceMiddle AgedGlobal HealthDisability-Adjusted Life YearsAgedGlobal Burden of DiseaseAdultQuality-Adjusted Life YearsForecasting

Stichwörter der Autor:innen

Degenerative mitral valve diseaseDisability-adjusted life yearsGlobal burden of diseaseMortalityPrevalence

Autor:innen und Institutionen

  • Interventional Center of Valvular Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Qiang Li, Yifan Yang, Xunan Guo, Jianxin Li, Xiangfeng Lu, Guangyuan Song

Zitieren

APA

Li, Q., Yang, Y., Lu, Z. N., Guo, X., Liu, X., Jiang, Z., Wu, W., Yin, C., Li, J., Lu, X., & Song, G. (2025). The Burden and Trends of Degenerative Mitral Valve Disease at the Global, Regional, and National Levels From 1990 to 2021, With Projections to 2035. Global Heart. https://doi.org/10.5334/gh.1489

Vancouver

Li Q, Yang Y, Lu ZN, Guo X, Liu X, Jiang Z, et al. The Burden and Trends of Degenerative Mitral Valve Disease at the Global, Regional, and National Levels From 1990 to 2021, With Projections to 2035. Global Heart. 2025. doi:10.5334/gh.1489

BibTeX
@article{Li2025,
  author = {Li, Qiang and Yang, Yifan and Lu, Zhi-Nan and Guo, Xunan and Liu, Xinmin and Jiang, Zhengming and Wu, Wenhui and Yin, Chengqian and Li, Jianxin and Lu, Xiangfeng and Song, Guangyuan},
  title = {The Burden and Trends of Degenerative Mitral Valve Disease at the Global, Regional, and National Levels From 1990 to 2021, With Projections to 2035},
  journal = {Global Heart},
  year = {2025},
  doi = {10.5334/gh.1489}
}
Kostenlos starten →